 | Up a level |
Schoepfer, A; Safroneeva, Ekaterina; Straumann, A (2016). How to measure disease activity in eosinophilic esophagitis. Diseases of the esophagus, 29(8), pp. 959-966. Blackwell Asia 10.1111/dote.12391
Straumann, A; Blanchard, C; Radonjic-Hoesli, Susanne; Bussmann, Ch; Hruz, P; Safroneeva, Ekaterina; Simon, Dagmar; Schoepfer, A M; Simon, Hans-Uwe (2016). A new eosinophilic esophagitis (EoE)-like disease without tissue eosinophilia found in EoE Families. Allergy, 71(6), pp. 889-900. Wiley-Blackwell 10.1111/all.12879
Simon, Dagmar; Cianferoni, A; Spergel, J M; Aceves, S; Holbreich, M; Venter, C; Rothenberg, M E; Terreehorst, I; Muraro, A; Lucendo, A J; Schoepfer, A; Straumann, A; Simon, Hans-Uwe (2016). Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy, 71(5), pp. 611-620. Wiley-Blackwell 10.1111/all.12846
Giriens, B; Yan, P; Safroneeva, E; Zwahlen, M; Reinhard, A; Nydegger, A; Vavricka, S; Sempoux, C; Straumann, A; Schoepfer, A M (2015). Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study. Allergy, 70(12), pp. 1633-1639. Wiley-Blackwell 10.1111/all.12733
Safroneeva, E; Coslovsky, Michael; Kuehni, C E; Zwahlen, M; Haas, N. A.; Panczak, R; Taft, T H; Hirano, I; Dellon, E S; Gonsalves, N; Leung, J; Bussmann, C; Woosley, J T; Yan, P; Romero, Y; Furuta, G T; Gupta, S K; Aceves, S S; Chehade, M; Straumann, A; ... (2015). Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity. Alimentary pharmacology & therapeutics, 42(8), pp. 1000-1010. Wiley-Blackwell 10.1111/apt.13370
Safroneeva, Ekaterina; Vavricka, S R; Fournier, N; Pittet, V; Peyrin-Biroulet, L; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease. Alimentary pharmacology & therapeutics, 42(8), pp. 977-989. Wiley-Blackwell 10.1111/apt.13363
Safroneeva, Ekaterina; Vavricka, S; Fournier, N; Seibold, Frank Werner; Mottet, C; Nydegger, A; Ezri, J; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary pharmacology & therapeutics, 42(5), pp. 540-548. Wiley-Blackwell 10.1111/apt.13307
Simon, Dagmar; Radonjic, Susanne Irene; Straumann, A; Yousefi, Shida; Simon, Hans-Uwe (2015). Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. Allergy, 70(4), pp. 443-452. Wiley-Blackwell 10.1111/all.12570
Straumann, A; Safroneeva, E (2012). Eosinophils in the gastrointestinal tract: friends or foes? Acta gastro-enterologica belgica, 75(3), pp. 310-5. Brussels: Acta medica belgica
Straumann, A; Aceves, S S; Blanchard, C; Collins, M H; Furuta, G T; Hirano, I; Schoepfer, A M; Simon, D; Simon, H-U (2012). Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy, 67(4), pp. 477-90. Oxford: Wiley-Blackwell 10.1111/j.1398-9995.2012.02787.x
Stuck, M C; Straumann, A; Simon, H-U (2011). Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy. Allergy, 66(5), pp. 705-7. Oxford: Wiley-Blackwell 10.1111/j.1398-9995.2010.02525.x
Straumann, A; Conus, S; Grzonka, P; Kita, H; Kephart, G; Bussmann, C; Beglinger, C; Smith, D A; Patel, J; Byrne, M; Simon, H-U (2010). Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut, 59(1), pp. 21-30. London: BMJ Publishing Group 10.1136/gut.2009.178558
Schoepfer, AM; Beglinger, C; Straumann, A; Trummler, M; Renzulli, P; Seibold, F (2009). Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflammatory bowel diseases, 15(12), pp. 1851-1858. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20986
Schoepfer, A M; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2008). Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy, 40(2), pp. 161-4. Stuttgart: Thieme 10.1055/s-2007-995345
Beglinger, C; Binek, J; Braegger, C; Michetti, P; Rogler, G; Sauter, B; Seibold, F; Straumann, A (2008). Infliximab Monotherapie versus Kombinationstherapie mit Immunmodulatoren. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), pp. 32-33. Neuhausen (CH): Rosenfluh
Straumann, A; Salvetti, M; Schoepfer, A (2008). Esoinphile Oesophagitis: eine Krankheit mit rasch wachsender Bedeutung. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(8), pp. 724-8. Basel: EMH Editores Medicorum Helveticorum
Netzer, P; Gschossmann, J; Straumann, A; Weimann, R; Sendensky, A; Schoepfer, AM (2007). Corticosteroid-dependent eosinophilic esophagitis: Azathioprine and 6-Mercaptopurine can induce and maintain long-term remission. European journal of gastroenterology & hepatology, 19(10), pp. 865-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e32825a6ab4
Schoepfer, AM; Bussmann, C; Zuber, M; Vannini, S; Straumann, A (2007). Procedure-induced Perforations and spontaneous ruptures in Eosinophilic Esophagitis: A Case Series and Review of the Literature. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 8S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2007). Esophageal strictures in Eosinophilic Esophagitis: Dilation is an Effective and Safe Therapeutic Alternative after Failure of Topical Corticosteroids. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 6S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Gschossmann, J; Seibold, F; Scheurer, U; Straumann, A (2007). Esophageal Strictures in Eosinophilic Esophagitis: Dilation is an effective and safe Alternative after Failure of topical Corticosteroids. Journal of Crohn's & Colitis(1), AP14. Amsterdam: Elsevier
Simon, D; Straumann, A; Wenk, A; Spichtin, H; Simon, H-U; Braathen, L R (2006). Eosinophilic esophagitis in adults--no clinical relevance of wheat and rye sensitizations. Allergy, 61(12), pp. 1480-3. Oxford: Wiley-Blackwell 10.1111/j.1398-9995.2006.01224.x
Bauerfeind, P; Beglinger, C; Beltinger, J; Braegger, C; Eigenmann, F; Fried, M; Guyot, J; Hürlimann, R; Michetti, P; Seibold, F; Straumann, A (2006). Infliximab - Recommendations practiques pour le traitment de la maladie de Crohn. Revue médicale suisse, 2(74), pp. 1807-15. Genève: Médecine & Hygiène
Schoepfer, A; Gschossmann, JM; Straumann, A; Sendensky, A; Weimann, R; Netzer, P (2006). Corticosteroid-dependent eosinophilic esophagitis. Azathioprine and 6-mercaptopurine can induce and maintain remission. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 6(Suppl 33), A38. Basel: EMH Editores Medicorum Helveticorum
